These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16854540)

  • 1. Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles.
    Luan X; Skupin M; Siepmann J; Bodmeier R
    Int J Pharm; 2006 Nov; 324(2):168-75. PubMed ID: 16854540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles.
    Luan X; Bodmeier R
    Eur J Pharm Biopharm; 2006 Jun; 63(2):205-14. PubMed ID: 16621485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles.
    Jaraswekin S; Prakongpan S; Bodmeier R
    J Microencapsul; 2007 Mar; 24(2):117-28. PubMed ID: 17454423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
    Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
    Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of sustained release microparticles with improved initial release property.
    Jung GY; Na YE; Park MS; Park CS; Myung PK
    Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
    Luan X; Bodmeier R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):143-9. PubMed ID: 16243496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
    Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres.
    Rojas J; Pinto-Alphandary H; Leo E; Pecquet S; Couvreur P; Fattal E
    Int J Pharm; 1999 Jun; 183(1):67-71. PubMed ID: 10361157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading.
    Ahmed AR; Bodmeier R
    Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
    Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
    Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
    Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of double-walled microparticles prepared with a modified water-in-oil-in-oil-in-water (w1/o/o/w3) method.
    Devrim B; Bozkır A
    J Microencapsul; 2013; 30(8):741-54. PubMed ID: 23631379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X; Song SK; Zhao P; Wei LM; Jiao HS
    Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
    Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
    J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.